Raleigh Neurology Associates Partners with athenahealth to Further Its Culture of Excellence in Neurology Care Delivery

3 years ago

One of the nation’s largest independent neurology practices adopts athenaOne® solution to increase staff satisfaction and meet the evolving needs…

iSIGN Reports First Quarter 2022 Results

3 years ago

SAN JOSE, CA / ACCESSWIRE / May 16, 2022 / iSign Solutions Inc. ("iSIGN") (OTC Pink:ISGN), a leading supplier of…

Empower Clinics Provides MCTO Update

3 years ago

VANCOUVER, BC / ACCESSWIRE / May 16, 2022 / Empower Clinics Inc. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (the "Company" or "Empower") is…

iTolerance, Inc. Pre-Clinical Non-Human Primate Study Demonstrates Long-Term Success of Allogeneic Islet Implantation Without Chronic Immunosuppression for the Treatment of Diabetes

3 years ago

Data published in peer-reviewed journal, Science AdvancesCo-implantation of allogeneic islets and streptavidin (SA)-FasL-presenting microgels sustained long-term (>6 months) survival of…

Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany

3 years ago

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the…

FGH to Acquire German Pharmaceutical Distributor

3 years ago

Franchise Global to Acquire German Pharmaceutical and Medical Cannabis Products Distributor, Strengthening its Position in the German Pharmaceutical and Medical…

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022

3 years ago

On track to report Phase 2 data for vurolenatide for short bowel syndrome and Phase 3 interim analysis for celiac…

Celcuity Inc. Announces $100 Million Private Placement

3 years ago

Proceeds to Advance Clinical Development of Gedatolisib Including Forthcoming Phase 3 Clinical Study (VIKTORIA-1)MINNEAPOLIS, MN / ACCESSWIRE / May 16,…

NeoGenomics Appoints Lynn Tetrault Interim CEO

3 years ago

FT. MYERS, FL / ACCESSWIRE / May 16, 2022 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused…

NanoViricides Reports that It Has Begun Drug Development to Combat Recent Cases of Severe Pediatric Hepatitis

3 years ago

SHELTON, CT / ACCESSWIRE / May 16, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the…